Evidence map›Paper›PMID 42108222›Full record

ArticleMedical physics2026

A modified lethal-potentially lethal model for oxygen-mediated FLASH sparing in stem cell niches.

Sumin Zhou

Abstract read
In one paragraph

Article in Medical physics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Sumin ZhouDepartment of Radiation Oncology, University of Nebraska Medical Center, Omaha, Nebraska, USA.

Funding

Tracking and Evaluation CoreU54GM115458 · NIGMS · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI ZHANG, YING · 2016 to 2025
$42.8M
NIGMS NIH HHS U54 GM115458
6 · The paper itself

Abstract

backgroundUltra-high dose rate (FLASH) irradiation can reduce normal-tissue toxicity while preserving tumor control, but a mechanistic explanation consistent with classical radiobiology remains incomplete. In particular, oxygen-depletion arguments based solely on bulk tissue oxygenation can appear inconsistent with clinically relevant fraction sizes, motivating a DNA-target-level oxygen formulation. PURPOSE: To develop a theory-based mechanistic extension of the Lethal and Potentially Lethal (LPL) model that explains oxygen-mediated FLASH trends without prescribing dose rate-dependent radiosensitivity, and to identify the baseline nuclear oxygen window in which sparing is expected to be largest.

methodsWe introduce an explicit Precursor Lesion population whose fate is governed by competing chemical restitution/repair versus oxygen-dependent fixation into potentially lethal and lethal lesion channels. Fixation kinetics are coupled to a time-varying nuclear oxygen tension,

resultsThe model predicts that oxygen-mediated FLASH sparing is largest when baseline nuclear oxygenation lies in an intermediate physiologic-hypoxia regime, corresponding to the steep oxygen-responsive portion of the OER curve. In the reference parameter set, a quiescent normal-tissue niche with baseline

conclusionsBy explicitly resolving Precursor Lesion fixation kinetics and by treating niche-to-nucleus oxygenation as an effective target-level variable, this mechanistic LPL framework predicts that oxygen-mediated FLASH sparing is most likely when baseline oxygenation lies within an intermediate physiologic-hypoxia window. The model should therefore be viewed as a mechanistic, testable framework rather than as a universal explanation of all FLASH responses.

Indexed as

Models, BiologicalOxygenRadiation DosageStem Cell NicheHumansKineticsRadiation ToleranceOxygenFLASH radiotherapyLPL modelnuclear oxygen depletionoxygen enhancement ratiostem cell niche

Identifiers

PMID42108222
PMCPMC13158172

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.